Cellectis S.A.
CLLS
$1.26
$0.0352.87%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 29.07M | 13.03M | 5.14M | 755.00K | 16.50M |
| Total Other Revenue | 6.97M | 6.61M | 6.99M | 8.44M | 8.03M |
| Total Revenue | 36.04M | 19.64M | 12.13M | 9.19M | 24.53M |
| Cost of Revenue | 167.00K | 167.00K | 167.00K | 167.00K | 691.00K |
| Gross Profit | 35.88M | 19.47M | 11.97M | 9.03M | 23.84M |
| SG&A Expenses | 18.82M | 16.88M | 16.95M | 16.81M | 13.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -192.00K | -5.00K | 153.00K | 299.00K | -1.13M |
| Total Operating Expenses | 114.00M | 107.49M | 106.40M | 105.50M | 97.52M |
| Operating Income | -77.96M | -87.86M | -94.27M | -96.30M | -72.99M |
| Income Before Tax | -106.81M | -101.07M | -105.08M | -138.29M | -100.40M |
| Income Tax Expenses | -508.00K | -343.00K | 108.00K | 370.00K | 451.00K |
| Earnings from Continuing Operations | -106.31 | -100.73 | -105.19 | -138.66 | -100.85 |
| Earnings from Discontinued Operations | 18.77M | 18.77M | 31.85M | 27.16M | 5.65M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.99M | 1.99M | 6.93M | 9.38M | 9.13M |
| Net Income | -85.55M | -79.97M | -66.41M | -102.13M | -86.08M |
| EBIT | -77.96M | -87.86M | -94.27M | -96.30M | -72.99M |
| EBITDA | -67.22M | -77.40M | -84.09M | -86.25M | -62.32M |
| EPS Basic | -1.09 | -1.17 | -1.10 | -1.77 | -1.70 |
| Normalized Basic EPS | -0.74 | -0.87 | -0.93 | -1.26 | -1.07 |
| EPS Diluted | -1.32 | -1.41 | -1.33 | -1.77 | -1.70 |
| Normalized Diluted EPS | -0.75 | -0.88 | -0.95 | -1.26 | -1.07 |
| Average Basic Shares Outstanding | 326.99M | 282.48M | 248.21M | 227.85M | 208.27M |
| Average Diluted Shares Outstanding | 358.27M | 313.76M | 279.50M | 227.85M | 208.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
